Clin Endosc.  2015 May;48(3):216-220. 10.5946/ce.2015.48.3.216.

Diagnostic Coding for Intramucosal Carcinoma and Neuroendocrine Tumor in the Colorectum: Proposal for Avoiding Confusing Coding in Korea

• Han DS
• Sohn JH
• Byeon JS
• Choi H
• Kim JM

• KMID: 2148569
• DOI: http://doi.org/10.5946/ce.2015.48.3.216

Abstract

Applying proper coding is important for doctors practicing gastroenterology. The coding systems established by various organizations define tumors differently. As a result of changing concepts of tumor classification, there are coding and reimbursement issues following the confirmation of malignant lesions by nationwide cancer screening in patients with intramucosal carcinoma and neuroendocrine tumors of the colorectum. In addition, there have been discrepancies between the views of endoscopists and pathologists regarding tumor coding. The Korean Society of Gastrointestinal Endoscopy held an expert meeting and established a consensus for the coding of intramucosal carcinoma and neuroendocrine tumor of the colorectum.

Keyword

Intramucosal carcinoma; Neuroendocrine tumors; Clinical coding

MeSH Terms

Classification
Clinical Coding*
Consensus
Early Detection of Cancer
Endoscopy, Gastrointestinal
Gastroenterology
Humans
Korea
Neuroendocrine Tumors*

Reference

1. Kim HG, Kim JO, Lee SH, et al. Clinical classification of colorectal epithelial tumors and proposal for diagnostic coding. Intest Res. 2011; 9:1–11.

2. World Health Organization. WHO Collaborating Centres for Classification of Diseases. International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. 2nd ed. Geneva: World Health Organization;2004.

3. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions esophagus, stomach, and colon November 30 to December 1 2002. Gastrointest Endosc. 2003; 58(6 Suppl):S3–S43. PMID: 14652541.

4. Cho MY, Kang YK, Kim KM, et al. Porposal for creating a guideline for cancer registration of the gastrointestinal tumors (I). Korean J Pathol. 2008; 42:140–150.

5. Jung ES, Kang YK, Cho MY, et al. Update on the proposal for creating a guideline for cancer registration of the gastrointestinal tumors (I-2). Korean J Pathol. 2012; 46:443–453. PMID: 23136571.

6. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology: ICD-O. 3rd ed. Geneva: World Health Organization;2000.

7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual. 7th ed. New York: Springer-Verlag;2010.

8. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon: IARC Press;2010.

9. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000; 47:251–255. PMID: 10896917.

10. Kim BC, Park CH, Kim TI, et al. Variable clinical classifications and diagnostic coding systems of colorectal neuroendocrine tumor. Intest Res. 2013; 11:14–22.

11. Rindi G, Klöppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007; 451:757–762. PMID: 17674042.

12. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996; 20:168–172. PMID: 8661813.

13. Ramage JK, Goretzki PE, Manfredi R, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology. 2008; 87:31–39. PMID: 18097130.

14. Park CH, Cheon JH, Kim JO, et al. Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread. Endoscopy. 2011; 43:790–795. PMID: 21735371.

15. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer. 2005; 103:1587–1595. PMID: 15742328.